Supplier
sandoz
Vilvoorde · BEL
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Awards
7
Total awarded
€2.6m
5 joint award(s) counted pro rata
Buyers
1
Sectors
1
Reg. BE 0457517227
Contracts this supplier holds that are running out
- €735,612
9 Feb 2027
stated - €663,632
9 Feb 2027
stated - €374,134
9 Feb 2027
stated - €56,119
9 Feb 2027
stated - €2,659,860
9 Feb 2027
stated - €25,603
9 Feb 2027
stated - €1,030,991
9 Feb 2027
stated
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Vancomycine voor intraveneuze toediening | UZ Leuven | sandoz, Viatris | €1,030,991 | 8 Oct 2026 |
| Piperacilline-Tazobactam voor intraveneuze toediening voor gebruik bij patiënten met ambulante parenterale antimicrobiële therapie (OPAT) | UZ Leuven | sandoz | €25,603 | 8 Oct 2026 |
| Piperacilline-Tazobactam voor intraveneuze toediening | UZ Leuven | Fresenius Kabi, sandoz, Viatris | €2,659,860 | 8 Oct 2026 |
| Cefuroxim voor intraveneuze toediening | UZ Leuven | Fresenius Kabi, sandoz | €56,119 | 8 Oct 2026 |
| Ceftazidim voor intraveneuze toediening | UZ Leuven | Fresenius Kabi, sandoz, Viatris | €374,134 | 8 Oct 2026 |
| Cefazoline voor intraveneuze toediening | UZ Leuven | sandoz, Viatris | €663,632 | 8 Oct 2026 |
| Amoxicilline-clavulaanzuur voor intraveneuze toediening | UZ Leuven | sandoz | €735,612 | 8 Oct 2026 |